echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Inventory of Chinese generic drugs opening the door of FDA

    Inventory of Chinese generic drugs opening the door of FDA

    • Last Update: 2014-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Many pharmaceutical companies in China claim that their products have passed the FDA certification, but some of them are only APIs, some of them have not been approved in the end although they have applied for them, in short, they have not entered the FDA's orange peel book Based on the partial data of xylophora and the query results of relevant data (incomplete statistics), the new Kangjie combed the preparation varieties that have passed the application of Anda in the United States and have been approved for production The following are the preparations produced by domestic pharmaceutical companies that can be listed in the United States Preparations approved for us market in China
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.